![N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine](https://static.cymitquimica.com/cas-image/383352-n-n-n-n-tetrakis-6-methyl-1h-benzimidazol-2-yl-methyl-ethane-12-diamine.png)
CAS: 81624-55-7 - N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine
Fórmula:C38H40N10
InChI:InChI=1/C38H40N10/c1-23-5-9-27-31(15-23)43-35(39-27)19-47(20-36-40-28-10-6-24(2)16-32(28)44-36)13-14-48(21-37-41-29-11-7-25(3)17-33(29)45-37)22-38-42-30-12-8-26(4)18-34(30)46-38/h5-12,15-18H,13-14,19-22H2,1-4H3,(H,39,43)(H,40,44)(H,41,45)(H,42,46)
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | NSC-348884 REF: IN-DA00G3SNCAS: 81624-55-7 | 98% | A consultar | Mar 10 Dic 24 |
 | NSC348884 REF: TM-T6909CAS: 81624-55-7 | 99.65% - 99.91% | 41,00 €~916,00 € | Mar 17 Dic 24 |
 | NSC348884 REF: TR-N900560CAS: 81624-55-7 | - - - | 1.049,00 € | Mar 21 Ene 25 |
 | NSC348884 REF: 3D-GDA62455CAS: 81624-55-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: IN-DA00G3SN
| 1g | A consultar | ||
| 5mg | 47,00 € | ||
| 10mg | 67,00 € | ||
| 25mg | 111,00 € | ||
| 50mg | 177,00 € | ||
| 100mg | 167,00 € | ||
| 250mg | 313,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
NSC348884
CAS:81624-55-7
NSC348884, a nucleophosmin inhibitor, disrupts oligomers, induces apoptosis, and inhibits cancer cell growth (IC50: 1.7-4.0 …
Fórmula:
C38H40N10
Pureza:
99.65% - 99.91%
Forma y color:
Solid
Peso molecular:
636.79
Ref: TM-T6909
| 2mg | 41,00 € | ||
| 5mg | 61,00 € | ||
| 10mg | 94,00 € | ||
| 25mg | 178,00 € | ||
| 50mg | 290,00 € | ||
| 100mg | 418,00 € | ||
| 500mg | 916,00 € | ||
| 1mL*10mM (DMSO) | 84,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
NSC348884
CAS:81624-55-7
NSC348884 is a novel anti-cancer drug that is an inhibitor of RNA polymerase. It has …
Fórmula:
C38H40N10
Pureza:
Min. 95%
Peso molecular:
636.79 g/mol
Ref: 3D-GDA62455
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
